Plasmacytoid Urothelial Carcinoma
- 1 March 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Surgical Pathology
- Vol. 33 (3), 417-424
- https://doi.org/10.1097/pas.0b013e318186c45e
Abstract
The plasmacytoid variant of urothelial carcinoma is rare, of which less than 40 cases have been reported in the English language literature. Herein we report the largest series to date of 17 cases of urothelial carcinoma with plasmacytoid features and report the associated clinicopathologic findings. The architectural pattern of the tumor varied from cells arranged in cords and single cells (35%), small nests (17%), solid sheetlike growth (29%), and diffuse discohesive patternless architecture (23%). The plasmacytoid component varied from 15% to 100% of the specimen analyzed; in 12 cases the plasmacytoid component composed greater than 50% of the tumor. The individual tumor cells had striking morphologic overlap with plasma cells with an eccentrically placed nucleus and abundant amphophilic to eosinophilic cytoplasm. The nuclei were of low to intermediate nuclear grade with minimal nuclear pleomorphism. Thirteen of 17 cases (76%) were associated with conventional high-grade invasive urothelial carcinoma and 9 cases showed very focal intracytoplasmic vacuoles mimicking signet ring cells. One case also showed sarcomatoid dedifferentiation. The tumor cells were positive for cytokeratin 7 (94%) and cytokeratin 20 (31%); CD138 was positive in 94% of cases. All cases were invasive -- 7 into at least the lamina propria, 7 into at least the muscularis propria, and 3 into perivesical fat. Follow-up information was available in 16 cases (range: 2 wk to 43 mo; mean 10 mo; median 5.5 mo). Eleven patients died of disease and 5 patients were alive with disease. Plasmacytoid variant of urothelial carcinoma is an aggressive subtype associated with poor prognosis. In limited samples, it may be misdiagnosed as chronic cystitis or plasmacytoma, a pitfall further compounded by CD138 expression. Distinction from metastatic carcinoma from other primary sites such as stomach and breast is critical due to differing therapeutic implications.This publication has 32 references indexed in Scilit:
- Radical Cystectomy for Carcinoma of the Bladder: 2,720 Consecutive Cases 5 Years LaterJournal of Urology, 2008
- Osteoclast-rich undifferentiated carcinomas of the urinary tractLaboratory Investigation, 2006
- Urothelial neoplasia with plasmacytoid morphologyHistopathology, 2005
- Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinomaHistopathology, 2005
- Urothelial Transitional Cell Carcinoma with Endophytic Growth PatternsThe American Journal of Surgical Pathology, 1997
- Radical Cystectomy for Carcinoma of the Bladder: Critical Evaluation of the Results in 1,026 CasesJournal of Urology, 1997
- Micropapillary Variant of Transitional Cell Carcinoma of the Urinary Bladder Histologic Pattern Resembling Ovarian Papillary Serous CarcinomaThe American Journal of Surgical Pathology, 1994
- Lymphoepithelioma-like Carcinoma of the Urinary BladderThe American Journal of Surgical Pathology, 1994
- Extramedullary Plasmacytoma of the Bladder: Case Report and Review of the LiteratureJournal of Urology, 1993
- Primary Signet-Ring Cell Carcinoma of the Urinary BladderAmerican Journal of Clinical Pathology, 1991